TOP 100 Swiss Startup Altoida Secures Investment From Hikma Ventures to Drive Better Clinical Outcomes For Brain Disease – Venturelab
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Jan. 14, 2020 - Altoida
Ioannis Tarnanas | Nature Portfolio Health Community
Altoida Receives Investment from Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator to Advance Precision Neurology
Handbook of Computational Neurodegeneration | SpringerLink
Loop | Ioannis Tarnanas
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
PDF) Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Interviews - Trinity Development & Alumni - Trinity College Dublin
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Ioannis Tarnanas's Page – iACToR
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas (@ITarnanas) | Twitter
Alzheimer europe virtual museum
Ioannis Tarnanas - Worldwebforum
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Ioannis Tarnanas presentations | SlideShare
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
